Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T

Journal of Clinical Investigation

Volumn 112, Issue 5, 2003, Pages 768-775

  Javadpour, Maryam M ^a   Tardiff, Jil C ^b   Pinz, Ilka ^a   Ingwall, Joanne S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MYOSIN; TROPOMYOSIN; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENERGY TRANSFER; HYDROLYSIS; MEASUREMENT; MISSENSE MUTATION; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; ENERGY METABOLISM; GENETICS; HEART CONTRACTION; HEART MUSCLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; MUTATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HUMANS; MICE; MUTATION; MYOCARDIAL CONTRACTION; MYOCARDIUM; TROPONIN T;

EID: 85047691343     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI15967     Document Type: Article

References (33)

1. Maron, B.J., Bonow, R.O., Cannon, R.O., 3rd, Leon, M.B., and Epstein, S.E. 1987. Hypertrophic carchomyopathy. Interrelations of clinical manifesrations, pathophysiology, and therapy. N. Engl. J. Med. 316:780-789.
2. Towbin, J.A. 2000. Molecular generics of hypertrophic cardiomyopathy. Curr. Cardiol Rep. 2:134-140.
3. Tobacman, L.S., et al. 2002. The croponin rail domain promotes a conformational scare of the chin filament that suppresses myosin activity. J. Biol. Chem. 277:27636-27642.
4. Maytum, R., Geeves, M.A., and Lehrer, S.S. 2002. A modulatory role for the troponin T rail domain in thin filament regulation. J. Biol. Chem. 277:29774-29780.
5. Greenfield, N.J., Palm, T., and Hirchcock-DeGregori, S.E. 2002. Structure and interactions of the carboxyl terminus of striated muscle alpha-tropomyosin: it is important to be flexible. Biophys. J. 83:2754-2766.
6. Palm, T., Graboski, S., Hitchcock-DeGregori, S.E., and Greenfield, N.J. 2001. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys. J. 81:2827-2837.
7. Maytum, R., Wesrerdorf, B., Jaquet K., and Geeves, M.A. 2003. Differential regulation of the actomyosin interaction by skeletal and cardiac troponin isoforms. J. Biol. Chem. 278:6696-6701.
8. Gomes. A.V., Guzman, G., Zhao, J., and Potter, J.D. 2002. Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J. Biol. Chem. 277:35341-35349.
9. Robinson, P., et al. 2002. Alterations in chin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J. Biol. Chem. 277:40710-40716.
10. Hinkle, A., and Tobacman, L.S. 2003. Folding and function of the troponin tail domain. Effects of cardiomyopathic troponin T mutations. J. Biol. Chem. 278:506-513.
11. Tian, R., and Ingwall, J.S. 1996. Energetic basis for reduced contractile reserve in isolated rat hearts. Am. J. Physiol. 270:H1207-H1216.
12. Tian, R., et al. 1997. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J. Clin. Invest. 99:745-751.
13. Tian, R., Nascimben, L., Ingwall, J.S., and Lorell, B.H. 1997. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation. 96:1313-1319.
14. Ingwall, J., and Neubauer, S. 1999. Heart Failure Reviews: The Energetics of the Failing Heart. 6-2-1999. Kluwer Academic Publishers. Norwell, Massachusetts, USA.
15. Jung, W.I., et al. 1998. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 97:2536-2542.
16. 403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin Invest. 101:1775-1783.
17. Tardiff, J.C., et al. 1999. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J. Clin. Invest. 104:469-481.
18. Ingwall, J.S., Saupe, K., and Spindler, M. 2002. Cardiovascular physiology in the genetically engineered mouse. 2nd edition. B.D. Hoit and R.A. Walsh, editors. Kluwer Academic Publishers. Norwell, Massachusetts, USA. 183-192.
19. Chu, G., et al. 1996. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 79:1064-1076.
20. Saupe, K.W., Spindler, M., Tian, R., and Ingwall, J.S. 1998. Impaired cardiac energecics in mice lacking muscle-specific isoenzymes of creacine kinase. Circ. Res. 82:898-907.
21. Ingwall, J.S. 1982. Phosphorus nuclear magnetic resonance speccroscopy of cardiac and skeletal muscles. Am. J. Physiol. 242:H729-H744.
22. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
23. Kammermeier, H. 1973. Miccoassay of free and total creatine from tissue extracts by combination of chromacographic and fluorometric methods. Anal. Biochem. 56:341-345.
24. Rosalki, S.B. 1967. An improved procedure for serum creatine phosphokinase determination. J. Lab. Clin. Med. 69:696-705.
25. Oblinger, M.M., Foe, L.G., Kwiackowska, D., and Kemp, R.G. 1988. Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport. J. Neurosci. Res. 21:25-34.
26. Bernstein, L.H., and Everse, J. 1970. Determination of the isoenzyme levels of lactate dehydrogenase. Methods Enzymol. 41:47-52.
27. Bergmeyer, H.U., and Gawehn, K. 1974. Methods of Enzymol analysis. Academic Press. New York, New York, USA. 466-467.
28. Polimeni, P.I., and Buraczewski, S.I. 1988. Expansion of extracellular tracer spaces in the isolated heart perfused with crystalloid solutions: expansion of extracellular space, trans-sarcolemmal leakage, of both? J. Mol. Cell. Cardiol. 20:15-22.
29. Lawson, J.W., and Veech, R.L. 1979. Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J. Biol. Chem. 254:6528-6537.
30. Veech, R.L., Lawson, J.W., Cornell, N.W., and Krebs, H.A. 1979. Cytosolic phosphorylation potential. J. Biol. Chem. 254:6538-6547.
31. Ingwall, J.S. 2002. ATP and the heart. Kluwer Academic Publishers. Norwell, Massachusetts, USA. 264 pp.
32. Sweeney, H.L., Feng, H.S., Yang, Z., and Watkins, H. 1998. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc. Natl. Acad. Sci. U. S. A. 95:14406-14410.
33. Knollmann, B.C., et al. 2001. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (179N) mutation linked to familial hypertrophic cardiomyopathy. J. Biol. Chem. 276:10039-10048.